JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.12% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5076
CALL
General Mills
GIS
$21B
| $312K | ﹤0.01% |
+4,900
| New | +$329K |
|
5077
Schwab 1-5 Year Corporate Bond ETF
SCHJ
$849M
| $311K | ﹤0.01% |
12,756
-230
| -2% | -$5.64K |
|
|
GRAL
5078
GRAIL Inc
GRAL
$3.03B
| $311K | ﹤0.01% |
17,404
-48,591
| -74% | -$790K |
|
5079
PUT
Nasdaq
NDAQ
$54.2B
| $309K | ﹤0.01% |
+4,000
| New | +$309K |
|
5080
Stereotaxis
STXS
$138M
| $307K | ﹤0.01% |
134,822
+110,909
| +464% | +$232K |
|
5081
FlexShares International Quality Dividend Index Fund
IQDF
$1.17B
| $302K | ﹤0.01% |
12,978
+2,752
| +27% | +$68.7K |
|
5082
Distribution Solutions Group
DSGR
$1.62B
| $302K | ﹤0.01% |
8,771
+38
| +0.4% | +$1.46K |
|
5083
Roadzen
RDZN
$122M
| $302K | ﹤0.01% |
138,352
+110,244
| +392% | +$136K |
|
|
SBT
5084
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $302K | ﹤0.01% |
63,349
+40,318
| +175% | +$191K |
|
5085
NLI Holdings
NL
$315M
| $301K | ﹤0.01% |
38,750
+16,393
| +73% | +$130K |
|
|
RGLS
5086
DELISTED
Regulus Therapeutics
RGLS
| $301K | ﹤0.01% |
190,457
+111,485
| +141% | +$171K |
|
|
SCPH
5087
DELISTED
scPharmaceuticals
SCPH
| $300K | ﹤0.01% |
84,827
+72,485
| +587% | +$278K |
|
5088
Flotek Industries
FTK
$1.3B
| $300K | ﹤0.01% |
31,497
+30,732
| +4,017% | +$209K |
|
|
SUNS
5089
Sunrise Realty Trust
SUNS
$105M
| $300K | ﹤0.01% |
21,280
+10,511
| +98% | +$152K |
|
5090
Invesco S&P MidCap Low Volatility ETF
XMLV
$749M
| $299K | ﹤0.01% |
4,919
| – | – |
|
|
TRML
5091
DELISTED
Tourmaline Bio
TRML
| $298K | ﹤0.01% |
14,705
-99
| -0.7% | -$2.49K |
|
|
ORC
5092
Orchid Island Capital
ORC
$1.32B
| $297K | ﹤0.01% |
38,139
-23,386
| -38% | -$184K |
|
5093
HireQuest
HQI
$234M
| $296K | ﹤0.01% |
20,939
+11,007
| +111% | +$156K |
|
5094
CALL
Futu Holdings
FUTU
$14.8B
| $296K | ﹤0.01% |
3,700
-17,200
| -82% | -$1.61M |
|
|
LNAI
5095
Lunai Bioworks
LNAI
$10.1M
| $296K | ﹤0.01% |
4,423
+3,260
| +280% | +$216K |
|
5096
Peoples Bancorp of North Carolina
PEBK
$239M
| $295K | ﹤0.01% |
9,429
+5,063
| +116% | +$145K |
|
5097
CALL
Vir Biotechnology
VIR
$1.56B
| $294K | ﹤0.01% |
+40,000
| New | +$316K |
|
|
5098
PUT
Vir Biotechnology
VIR
$1.56B
| $294K | ﹤0.01% |
+40,000
| New | +$316K |
|
|
JNPR
5099
CALL
DELISTED
Juniper Networks
JNPR
| $292K | ﹤0.01% |
7,800
| – | – |
|
5100
NN Inc
NNBR
$322M
| $292K | ﹤0.01% |
89,265
+69,149
| +344% | +$264K |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.